Technavio has been monitoring the rapid influenza diagnostic tests market and it is poised to grow by USD 0.89 billion during 2020-2024, at a CAGR of 11% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200519005687/en/
Technavio has announced its latest market research report titled Global Rapid Influenza Diagnostic Tests Market 2020-2024 (Graphic: Business Wire)
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Please Request Free Sample Report on COVID-19 Impact
The market is concentrated, and the degree of concentration will decelerate during the forecast period. Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Hologic Inc., Quidel Corp., Siemens Healthineers AG, and Thermo Fisher Scientific Inc. are some of the major market participants. The rising demand for POCT will offer immense growth opportunities. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Rising demand for POCT has been instrumental in driving the growth of the market. However, might hamper the market growth.
Rapid Influenza Diagnostic Tests Market 2020-2024: Segmentation
Rapid Influenza Diagnostic Tests Market is segmented as below:
- Product
- RIDTs For Influenza A
- RIDTs For Influenza B
- Geography
- North America
- Europe
- Asia
- ROW
To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43741
Rapid Influenza Diagnostic Tests Market 2020-2024: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our rapid influenza diagnostic tests market report covers the following areas:
- Rapid Influenza Diagnostic Tests Market size
- Rapid Influenza Diagnostic Tests Market trends
- Rapid Influenza Diagnostic Tests Market industry analysis
This study identifies rising government initiatives as one of the prime reasons driving the rapid influenza diagnostic tests market growth during the next few years.
Rapid Influenza Diagnostic Tests Market 2020-2024: Vendor Analysis
We provide a detailed analysis of vendors operating in the rapid influenza diagnostic tests market, including some of the vendors such as Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Hologic Inc., Quidel Corp., Siemens Healthineers AG, and Thermo Fisher Scientific Inc. Backed with competitive intelligence and benchmarking, our research reports on the rapid influenza diagnostic tests market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Rapid Influenza Diagnostic Tests Market 2020-2024: Key Highlights
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will assist rapid influenza diagnostic tests market growth during the next five years
- Estimation of the rapid influenza diagnostic tests market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the rapid influenza diagnostic tests market
- Analysis of the market's competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of rapid influenza diagnostic tests market vendors
Table Of Contents:
Executive Summary
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 2024
Five Forces Analysis
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- RIDTs for influenza A Market size and forecast 2019-2024
- RIDTs for influenza B Market size and forecast 2019-2024
- Market opportunity by Product
Market Segmentation by End-user
- Market segments
- Comparison by End user
- Hospitals and diagnostic laboratories Market size and forecast 2019-2024
- Academic and research centers Market size and forecast 2019-2024
- Homecare Market size and forecast 2019-2024
- Market opportunity by End user
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America Market size and forecast 2019-2024
- Europe Market size and forecast 2019-2024
- Asia Market size and forecast 2019-2024
- ROW Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Volume drivers Demand led growth
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- Hologic Inc.
- Quidel Corp.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200519005687/en/
Contacts:
Technavio Research
Jesse Maida
Media Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/